Table 3 Clinical characteristics of patients treated with accelerated BT protocol and remaining in hospital longer than 24 h post BT
From: Safety of delivering bronchial thermoplasty in two treatment sessions
Hospital stay ≤ 24 h | Hospital stay > 24 h | p | |
|---|---|---|---|
n | 9 | 7 | |
Age (years) | 50.0 (20) | 48 (25) | 0.918 |
Male: Female | 6:3 | 1:6 | 0.060a |
BMI (kg/m2) | 34 (11) | 36 (13) | 0.210 |
ACQ | 3.2 (1.6) | 3.6 (1.6) | 0.918 |
FEV1 (% predicted) | 45.7 (22.8) | 56.5 (15.9) | 0.681 |
Exacerbations (6 months) | 2 (5) | 4 (5) | 1.000 |
Prednisolone (mg/d) | 0 (25) | 20 (30) | 0.210 |
Inhaled Steroids (eq/d) | 1600 (1000) | 2000 (2000) | 0.351 |
SABA (puffs/d) | 12 (18.5) | 12 (6) | 0.837 |
Activations | 180 (49) | 172 (36) | 0.272 |